Hypofrontality does not occur with 6-hydroxydopamine lesions of the medial prefrontal cortex in rat brain

By Kurachi M.   Yasui S.-I.   Kurachi T.   Shibata R.   Murata M.   Hagino H.   Tanii Y.   Kurata K.   Suzuki M.   Sakurai Y.  

European Neuropsychopharmacology, Vol. 5, Iss. 1, 1995-03 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite

Effect of 6-hydroxydopamine lesions of the medial prefrontal cortex of the rat on performance in a reaction time task

By Sakurai Y.   Shibata R.   Kurachi M.  

European Neuropsychopharmacology, Vol. 5, Iss. 1, 1995-03 ,pp. : 69-73

Elsevier

Access to resources Recommend Favorite

Effects of Tandospirone on Second Messenger Systems and Neurotransmitter Release in the Rat Brain

By Tanaka H.   Tatsuno T.   Shimizu H.   Hirose A.   Kumasaka Y.   Nakamura M.  

General Pharmacology, Vol. 26, Iss. 8, 1995-12 ,pp. : 1765-1772

Elsevier

Access to resources Recommend Favorite

NMDA receptor antagonists ameliorate the stepping deficits produced by unilateral medial forebrain bundle injections of 6-OHDA in rats

By Kelsey John   Mague Stephen   Pijanowski Reyna   Harris Ryan   Kleckner Nancy   Matthews Russell  

Psychopharmacology, Vol. 175, Iss. 2, 2004-09 ,pp. : 179-188

Springer Publishing Company

Access to resources Recommend Favorite

Temporal changes of dopaminergic and glutamatergic receptors in 6-hydroxydopamine-treated rat brain

By Araki T.   Tanji H.   Kato H.   Imai Y.   Mizugaki M.   Itoyama Y.  

European Neuropsychopharmacology, Vol. 10, Iss. 5, 2000-09 ,pp. : 365-375

Elsevier

Access to resources Recommend Favorite